Prostate Cancer Reports

Volume 1 Number 8
 August 2013

Home > Prostate Cancer Reports > Volume 1 - Year 2013 > Number 8, August 2013


Localized PCa
Locally advanced PCa


Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH, Penson DF, Zietman AL.
Early Detection of Prostate Cancer: AUA Guideline.
J Urol. 2013 Aug;190(2):419-26. doi: 10.1016/j.juro.2013.04.119. Epub 2013 May 6.
Abstract | Full text (Journal) | Full text (AUA) | Related citations

Heidenreich A, Abrahamsson PA, Artibani W, Catto J, Montorsi F, Van Poppel H, Wirth M, Mottet N.
Early detection of prostate cancer: European association of urology recommendation.
Eur Urol. 2013 Sep;64(3):347-54. doi: 10.1016/j.eururo.2013.06.051. Epub 2013 Jul 9.
Abstract | Related citations

Horwich A, Parker C, de Reijke T, Kataja V; on behalf of the ESMO Guidelines Working Group. These Clinical Practice Guidelines are endorsed by the Japanese Society of Medical Oncology (JSMO).
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2013 Jun 27. [Epub ahead of print]
Abstract | Full text | Related citations

[No authors listed]
Abstracts of the Prostate Cancer World Congress & 14th Australasian Prostate Cancer Conference. Melbourne, Australia. August 6-10, 2013.
BJU Int. 2013 Aug;112 Suppl 1:3-70. doi: 10.1111/bju.12292.
Abstract | Full text | Related citations


Integrative medicine

Bosland MC, Kato I, Zeleniuch-Jacquotte A, Schmoll J, Enk Rueter E, Melamed J, Kong MX, Macias V, Kajdacsy-Balla A, Lumey LH, Xie H, Gao W, Walden P, Lepor H, Taneja SS, Randolph C, Schlicht MJ, Meserve-Watanabe H, Deaton RJ, Davies JA.
Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.
JAMA. 2013 Jul 10;310(2):170-8. doi: 10.1001/jama.2013.7842.
Abstract | Comment in | Related citations | News

Jonsson F, Yin L, Lundholm C, Smedby KE, Czene K, Pawitan Y.
Low-dose aspirin use and cancer characteristics: a population-based cohort study.
Br J Cancer. 2013 Jul 25. doi: 10.1038/bjc.2013.411. [Epub ahead of print]
Abstract | Related citations


Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, Frenette PS.
Autonomic nerve development contributes to prostate cancer progression.
Science. 2013 Jul 12;341(6142):1236361. doi: 10.1126/science.1236361.
Abstract | Related citations

Psychosocial aspects

Gupta D, Braun DP, Staren ED.
Prognostic value of changes in quality of life scores in prostate cancer.
BMC Urol. 2013 Jul 10;13(1):32. [Epub ahead of print]
Abstract | Full text | Related citations


Jackson WC, Johnson SB, Li D, Foster C, Foster B, Song Y, Schipper M, Shilkrut M, Sandler HM, Morgan TM, Palapattu GS, Hamstra DA, Feng FY.
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy.
Radiat Oncol. 2013 Jul 8;8:170. doi: 10.1186/1748-717X-8-170.
Abstract | Full text | Related citations

Treatment complications

Cronin-Fenton DP, Antonsen S, Cetin K, Daniels A, Borre M, Acquavella J, Lash TL.
Mortality and incidence of new primary cancers in men with prostate cancer: A Danish population-based cohort study.
Cancer Epidemiol. 2013 Jul 3. doi:pii: S1877-7821(13)00101-X. 10.1016/j.canep.2013.06.002. [Epub ahead of print]
Abstract | Related citations

Droupy S, Al Said B, Lechevallier E, Colson MH, Giuliano F.
[Sexuality and prostate cancer].
Prog Urol. 2013 Jul;23(9):696-711. doi: 10.1016/j.purol.2013.03.011. Epub 2013 May 31. French.
Abstract | Related citations

Weber MF, Smith DP, O'Connell DL, Patel MI, de Souza PL, Sitas F, Banks E.
Risk factors for erectile dysfunction in a cohort of 108 477 Australian men.
Med J Aust. 2013;199(2):107-11. Epub 2013 Jul 22.
Abstract | Full text | Related citations


Active surveillance

Blázquez C, Hernández V, de la Peña E, Díaz FJ, Martin MD, de la Morena JM, Llorente C.
Oncological Outcomes in Patients Potentially Eligible for Active Surveillance who Underwent Radical Prostatectomy.
Actas Urol Esp. 2013 Jul 10. doi:pii: S0210-4806(13)00163-0. 10.1016/j.acuro.2013.02.015. [Epub ahead of print]
Abstract | Related citations

Gleason score

Jackson W, Hamstra DA, Johnson S, Zhou J, Foster B, Foster C, Li D, Song Y, Palapattu GS, Kunju LP, Mehra R, Feng FY.
Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy.
Cancer. 2013 Jul 2. doi: 10.1002/cncr.28215. [Epub ahead of print]
Abstract | Related citations

Integrative medicine

Hamilton-Reeves JM, Banerjee S, Banerjee SK, Holzbeierlein JM, Thrasher JB, Kambhampati S, Keighley J, Van Veldhuizen P.
Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.
PLoS One. 2013 Jul 12;8(7):e68331. doi: 10.1371/journal.pone.0068331. Print 2013.
Abstract | Full text | Related citations

Oncological outcomes

Tsurusaki T, Yamasaki Y, Maruta S.
[Outcome after radical prostatectomy with extended pelvic lymphadenectomy for untreated high-risk clinically localized prostate cancer].
Nihon Hinyokika Gakkai Zasshi. 2013 May;104(3):496-504. Japanese.
Abstract | Related citations


Bolton DM, Ta A, Bagnato M, Muller D, Lawrentschuk NL, Severi G, Syme RR, Giles GG.
Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer.
World J Urol. 2013 Jul 4. [Epub ahead of print]
Abstract | Full text | Related citations

Kapoor J, Namdarian B, Pedersen J, Hovens C, Moon D, Peters J, Costello AJ, Ruljancich P, Corcoran NM.
Extraprostatic Extension into Periprostatic Fat is a More Important Determinant of Prostate Cancer Recurrence than an Invasive Phenotype.
J Urol. 2013 Jun 29. doi:pii: S0022-5347(13)04667-3. 10.1016/j.juro.2013.06.050. [Epub ahead of print]
Abstract | Related citations

Lee S, Jeong CW, Jeong SJ, Hong SK, Choi W, Byun SS, Lee SE.
The Prognostic Value of Pathologic Prostate-specific Antigen Mass Ratio in Patients With Localized Prostate Cancer With Negative Surgical Resection Margins.
Urology. 2013 Jul 3. doi:pii: S0090-4295(13)00567-0. 10.1016/j.urology.2013.04.040. [Epub ahead of print]
Abstract | Related citations

Ouzzane A, Rozet F, Salas RS, Galiano M, Barret E, Prapotnich D, Cathelineau X.
Positive surgical margins after minimally invasive radical prostatectomy in patients with pT2 and pT3a disease could be considered pathological upstaging.
BJU Int. 2013 May 23. doi: 10.1111/bju.12249. [Epub ahead of print]
Abstract | Related citations

Rouanne M, Rode J, Campeggi A, Allory Y, Vordos D, Hoznek A, Abbou CC, La Taille AD, Salomon L.
Long-term impact of positive surgical margins on biochemical recurrence after radical prostatectomy: Ten years of follow-up.
Scand J Urol. 2013 Jul 24. [Epub ahead of print]
Abstract | Related citations


Wæhre H, Vlatkovic L, Cvancarova M, Paus E, Fosså SD, Danielsen HE.
Fifteen-year mortality after radical prostatectomy: Which factors are available for patient counselling?
Scand J Urol. 2013 Jul 25. [Epub ahead of print]
Abstract | Related citations


Cheng JY.
The Prostate Cancer Intervention Versus Observation Trial (PIVOT) in Perspective.
J Clin Med Res. 2013 Aug;5(4):266-8. doi: 10.4021/jocmr1395w. Epub 2013 Jun 21.
Abstract | Full text | Related citations

de Castro Abreu AL, Bahn D, Leslie S, Shoji S, Silverman P, Desai MM, Gill IS, Ukimura O.
Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.
BJU Int. 2013 Aug;112(3):298-307. doi: 10.1111/bju.12151.
Abstract | Full text | Related citations

Glass AS, Punnen S, Cooperberg MR.
Divorcing diagnosis from treatment: contemporary management of low-risk prostate cancer.
Korean J Urol. 2013 Jul;54(7):417-25. doi: 10.4111/kju.2013.54.7.417. Epub 2013 Jul 15.
Abstract | Full text | Related citations

Jackson WC, Johnson SB, Feng FY, Hamstra DA.
Salvage Radiation Therapy Improves Metastasis-free Survival for Clinically Aggressive and Indolent Prostate Cancer Recurrences After Radical Prostatectomy.
Am J Clin Oncol. 2013 Jul 3. [Epub ahead of print]
Abstract | Related citations

Nguyen HD, Allen BJ, Pow-Sang JM.
Focal cryotherapy in the treatment of localized prostate cancer.
Cancer Control. 2013 Jul;20(3):177-80.
Abstract | Full text | Related citations

Rassweiler J, Rassweiler MC, Kenngott H, Frede T, Michel MS, Alken P, Clayman R.
The past, present and future of minimally invasive therapy in urology: A review and speculative outlook.
Minim Invasive Ther Allied Technol. 2013 Aug;22(4):200-9. doi: 10.3109/13645706.2013.816323. Epub 2013 Jun 30.
Abstract | Related citations

Treatment comparison

Ferrer M, Guedea F, Suárez JF, de Paula B, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Boladeras A, Ayala A, Craven-Bratle J, Avila M, Cunillera O, Pardo Y, Alonso J, Aguiló F; Clinically Localized Prostate Cancer.
Quality of life impact of treatments for localized prostate cancer: Cohort study with a 5year follow-up.
Radiother Oncol
. 2013 Jul 9. doi:pii: S0167-8140(13)00295-8. 10.1016/j.radonc.2013.05.038. [Epub ahead of print]
Abstract | Related citations

Laviana AA, Hu JC.
A comparison of the robotic-assisted versus retropubic radical prostatectomy.
Minerva Urol Nefrol. 2013 Sep;65(3):161-70. Italian
Abstract | Related citations

Treatment complications

Murray L, Henry A, Hoskin P, Siebert FA, Venselaar J; BRAPHYQS/PROBATE group of the GEC ESTRO.
Second primary cancers after radiation for prostate cancer: a review of data from planning studies.
Radiat Oncol. 2013 Jul 8;8:172. doi: 10.1186/1748-717X-8-172.
Abstract | Full text | Related citations



Sheets NC, Hendrix LH, Allen IM, Chen RC.
Trends in the use of postprostatectomy therapies for patients with prostate cancer: A Surveillance, Epidemiology, and End Results Medicare analysis.
Cancer. 2013 Jul 10. doi: 10.1002/cncr.28222. [Epub ahead of print]
Abstract | Related citations